Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted Therapies for Eosinophilic Gastrointestinal Disorders
Alfredo J. Lucendo, Piedad López-Sánchez
BioDrugs (2020) Vol. 34, Iss. 4, pp. 477-493
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 69
The use of biologics in food allergy
Alessandro Fiocchi, Brian P. Vickery, Robert A. Wood
Clinical & Experimental Allergy (2021) Vol. 51, Iss. 8, pp. 1006-1018
Closed Access | Times Cited: 71
The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective
Eden David, Benjamin Ungar, Yael Renert‐Yuval, et al.
Clinical & Experimental Allergy (2023) Vol. 53, Iss. 2, pp. 156-172
Closed Access | Times Cited: 30
Epidemiology and risk factors for eosinophilic esophagitis: lessons for clinicians
Ángel Arias, Alfredo J. Lucendo
Expert Review of Gastroenterology & Hepatology (2020) Vol. 14, Iss. 11, pp. 1069-1082
Closed Access | Times Cited: 46
Utilizing Deep Learning to Analyze Whole Slide Images of Colonic Biopsies for Associations Between Eosinophil Density and Clinicopathologic Features in Active Ulcerative Colitis
Niels Vande Casteele, Jonathan A. Leighton, Shabana F. Pasha, et al.
Inflammatory Bowel Diseases (2021) Vol. 28, Iss. 4, pp. 539-546
Closed Access | Times Cited: 40
Evidence-based treatments for eosinophilic esophagitis: insights for the clinician
Sara Feo‐Ortega, Alfredo J. Lucendo
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 28
EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe
Alfredo J. Lucendo, Cecílio Santander, Edoardo Savarino, et al.
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 21
Helicobacter pylori as a potential cause of reversible esophageal eosinophilia
Nimrod Moss Ophir, Anton Bermont, Daniel L. Cohen, et al.
(2025)
Closed Access
Management of eosinophil-associated inflammatory diseases: the importance of a multidisciplinary approach
Santiago Quirce, Borja G. Cosío, Agustı́n España, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Human differentiated eosinophils release IL-13 in response to IL-33 stimulation
Amiko M. Uchida, Gabrielle Ro, Qiang Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders
Naoya Arakawa, Hisako Yagi, Mariko Shimizu, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 112-112
Open Access | Times Cited: 8
Searching for Noninvasive Predictors of the Diagnosis and Monitoring of Eosinophilic Esophagitis—The Importance of Biomarkers of the Inflammatory Reaction Involving Eosinophils
Joanna Sarbinowska, Benita Wiatrak, Dorota Waśko−Czopnik
Biomolecules (2021) Vol. 11, Iss. 6, pp. 890-890
Open Access | Times Cited: 12
Duodenal stenosis, an unusual presentation of eosinophilic gastroenteritis: a case report
Clelia Di Mari, Elena Pozzi, C. Mantegazza, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 1
Biologics for eosinophilic oesophagitis: a systematic review and meta-analysis
Beibei Zeng, Dao‐Yong Jia, Shengen Li, et al.
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Drug treatment strategies for eosinophilic esophagitis in adults
Alfredo J. Lucendo
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 7, pp. 827-840
Closed Access | Times Cited: 4
Eosinophilic esophagitis: from pathophysiology to management
Matteo Ghisa, Giorgio Laserra, Daria Maniero, et al.
Minerva Gastroenterology (2022) Vol. 68, Iss. 1
Closed Access | Times Cited: 3
Eosinophilic gastrointestinal disorders: new perspectives and the emerging role of biological therapies
Francesca Losa, Arianna Cingolani
(2023), pp. 60-72
Open Access | Times Cited: 1
Vasoactive Intestinal Peptide Receptor, CRTH2, Antagonist Treatment Improves Eosinophil and Mast Cell-Mediated Esophageal Remodeling and Motility Dysfunction in Eosinophilic Esophagitis
Chandra Sekhar Yadavalli, Sathisha Upparahalli Venkateshaiah, Alok Kumar Verma, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 295-295
Open Access
Zooming in on T cell clones: Are we heading to personalized treatment of allergy?
Netali Ben-Baruch Morgenstern, Mark Rochman, Marc E. Rothenberg
Science Immunology (2021) Vol. 6, Iss. 62
Closed Access | Times Cited: 2
Non-esophageal eosinophilic gastrointestinal disorders
Xiuxu Chen, Xianzhong Ding, Huaibin M. Ko
Human Pathology Reports (2022) Vol. 29, pp. 300655-300655
Closed Access | Times Cited: 1
Eosinophilic gastroenteritis – a manifestation of an allergic disease in the gastrointestinal tract? Part 2. Treatment
Andrzej Kuźmiński, Tomasz Rosada, Justyna Przybyszewska, et al.
Gastroenterology Review (2022) Vol. 18, Iss. 2, pp. 135-140
Open Access | Times Cited: 1
Immunosuppressants and immune modulators in luminal gastroenterology
Alastair Forbes
Best Practice & Research Clinical Gastroenterology (2021) Vol. 54-55, pp. 101759-101759
Closed Access | Times Cited: 1
Editorial: Food allergy: from defense to attack
Alessandro Fiocchi, Motohiro Ebisawa
Current Opinion in Allergy and Clinical Immunology (2021) Vol. 21, Iss. 3, pp. 261-262
Closed Access | Times Cited: 1
A Case of Eosinophilic Gastroenteritis with Ascites as the First Symptom and Literature Review
昕 马
Advances in Clinical Medicine (2022) Vol. 12, Iss. 01, pp. 40-44
Closed Access
An Adalimumab-Induced Mucosal Red Storm in a Patient with Crohn’s Disease
Dania Hudhud, Kristen Stashek, Lauren George, et al.
Digestive Diseases and Sciences (2022) Vol. 67, Iss. 2, pp. 453-456
Closed Access
Page 1 - Next Page

Scroll to top